Machado, A.P.; Shaikh, A.S.; Saji, A.; Shatila, M.; Oliva, I.G.; Wang, Y.; Shirwaikar Thomas, A.
Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer. Cancers 2024, 16, 1919.
https://doi.org/10.3390/cancers16101919
AMA Style
Machado AP, Shaikh AS, Saji A, Shatila M, Oliva IG, Wang Y, Shirwaikar Thomas A.
Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer. Cancers. 2024; 16(10):1919.
https://doi.org/10.3390/cancers16101919
Chicago/Turabian Style
Machado, Antonio Pizuorno, Abdullah Salim Shaikh, Alice Saji, Malek Shatila, Isabella Glitza Oliva, Yinghong Wang, and Anusha Shirwaikar Thomas.
2024. "Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer" Cancers 16, no. 10: 1919.
https://doi.org/10.3390/cancers16101919
APA Style
Machado, A. P., Shaikh, A. S., Saji, A., Shatila, M., Oliva, I. G., Wang, Y., & Shirwaikar Thomas, A.
(2024). Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer. Cancers, 16(10), 1919.
https://doi.org/10.3390/cancers16101919